Hematology Frontier

Editor’s Note: On October 31, 2025, the International Conference on Cellular Therapy and Biomedical Frontiers, hosted by the Xiong’an Institute for Engineering–Medicine Translational Research of Peking University People’s Hospital and…

Editor’s Note: Cellular therapy has emerged as a breakthrough treatment modality, showing remarkable efficacy across various hematologic malignancies. However, its application in chronic lymphocytic leukemia (CLL) continues to face notable…

2025 International Conference on Cell Therapy and Biomedical Frontiers Editor’s Note: On October 31, 2025, the International Conference on Cell Therapy and Biomedical Frontiers was successfully held in Xiong’an, Hebei…

2025 International Conference on Cell Therapy and Biomedical Frontiers Editor’s Note: On October 31, 2025, the International Conference on Cell Therapy and Biomedical Frontiers was grandly held in Xiong’an, Hebei…

On November 2, 2025, world-renowned hematology experts Professor Michael R. Bishop, Director of the Cell Therapy Center at the University of Chicago, and Professor Edmund K. Waller, the Rein Saral Distinguished Chair at Emory University, visited the Peking University Institute of Hematology for an academic exchange.

Editor’s Note: In the golden season of autumn, leading experts gathered in the City of the Future to discuss the frontiers of cell therapy. On October 31, 2025, the 2025…

Editor’s Note: As autumn brings its golden harvest, scientific progress likewise flourishes. The 2025 Chinese Research Hospital Association Conference on Cell Therapy and Biomedical Frontiers, jointly organized by the Cell…

Editor’s Note: Universal CAR-T cell therapy has emerged as one of the most dynamic frontiers in cellular immunotherapy. Characterized by its “off-the-shelf” availability and broad clinical potential, it has drawn…

Editor’s Note: With the rapid development of medical technology, modern lymphoma treatment has become a key focus in the field of oncology. From May 25 to 26, the Modern Lymphoma…